isaloser- you are so out of controldude, bringing a drug to market in canada is extremely difficult, expensive and time consuming. That said, sure, mistakes were made. However, most if not all public companies make mistakes. The key is learning from them. I think this drug has a chance to earn some decent revenues if it makes it to market in any of the targeted conditions. If it makes it in a few of them, the revenues could be worth the wait.
If you were a normal seasoned investor, you would either sell, or hold or buy more. But to whine incessantly like you do is really embarrassing for you. I feel badly for you...you make yourself out to be such an idiot and so publicly too.
I think prakash should help a lot. As we go through these last trials and approvals hopefully come, he should be a big help to getting the story out there to the right people, something this company needs to do more of and needs to do well. It has not always been so. Lets hope they've learned from past mistakes. Comments like backflips and carthweels are not helpful and frankly, amateurish...so in that sense, lessons must be taken and improved on without any ego getting in the way. Does the drug work? We shall soon see. Trials are one thing- marketing it, selling it, profiting from it are another. I hope prakash takes note and works on getting some simple easy to digest guidance of what conditions are being targeted, their total market potential, what isa can reasonably expect revenue wise IF they make it to market and in what time frame. What are adoption rates, and what total revenues can we look to after all expenses. I think it should be a relatively easy document to put together and would very much help current and potential investors understand this companies potential. It MUST be a simple document, digestable to the lay person. If it gets too fragmented or technical, you lose the audience. Personally speaking, I find it VERY CONFUSING to understand all of the various markets this company is involved in....and what the potential of these markets is to ISA...I dont care that the total global market for TX is xyz...what I do care about is having guidance as to what is REASONABLE for isa based on very conservative guesstimates.